Research Insight
University of Rochester Spearheads FDA Initiative to Speed Development of New Therapies
Pain is the most common symptom leading patients to see a physician in the United States, yet the most widely prescribed medications – opioids...
News
Dako and Quintiles form alliance to speed development of personalized medicine
Dako, a Danish-based world leader in tissue-based cancer diagnostics, and Quintiles, the world’s leading bio pharmaceutical services companies, announced a strategic alliance to advance...
Industry Reports
GlaxoSmithKline announced third quarter results-Net Sales growth of 14% compared to the previous quarter
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the third quarter ended 30th September 2010. The Company has posted a Net Sales growth...
News
Pfizer’s Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
Pfizer Inc announced today that the Japanese Ministry of Health, Labour and Welfare approved Lyrica® (pregabalin) capsules for the treatment of peripheral...
Uncategorized
News Letters
{japopup type="iframe" content="https://www.worldpharmatoday.com/E-Newsletter/Nov-10/" title="October Issue" width="700" height="480"} October Issue - World Pharma Today - Monthly Newsletter{/japopup}
News
PRADAX gains approval in Canada for stroke prevention in atrial fibrillation
Health Canada, the Canadian health authority, has approved PRADAX™ (dabigatran etexilate), 1 Boehringer Ingelheim’s novel, oral direct thrombin inhibitor 2 for the prevention of...
Industry Reports
Bayer lifts sales-Grow by 16.1 percent to EUR 8,581 million
The Bayer Group significantly raised sales and underlying earnings in the third quarter of 2010. “We are pleased that our third-quarter results showed an...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read